Maple Capital Management, Inc. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Maple Capital Management, Inc. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2017$117,000
+20.6%
14,0000.0%0.04%
+16.7%
Q4 2016$97,000
+36.6%
14,0000.0%0.03%
+30.4%
Q3 2016$71,000
-15.5%
14,0000.0%0.02%
-25.8%
Q2 2016$84,000
+31.2%
14,0000.0%0.03%
+29.2%
Q1 2016$64,000
+1.6%
14,0000.0%0.02%
+9.1%
Q4 2015$63,000
+43.2%
14,0000.0%0.02%
+37.5%
Q3 2015$44,000
+4.8%
14,0000.0%0.02%
+14.3%
Q2 2015$42,000
+2.4%
14,0000.0%0.01%0.0%
Q1 2015$41,000
-33.9%
14,0000.0%0.01%
-36.4%
Q4 2014$62,00014,0000.02%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2016
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders